rs59650398

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_021098.3(CACNA1H):​c.994G>A​(p.Ala332Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0168 in 1,611,106 control chromosomes in the GnomAD database, including 305 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.014 ( 23 hom., cov: 33)
Exomes 𝑓: 0.017 ( 282 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3O:1

Conservation

PhyloP100: -0.957

Publications

10 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0031196177).
BP6
Variant 16-1200446-G-A is Benign according to our data. Variant chr16-1200446-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 460196.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.014 (2135/152254) while in subpopulation SAS AF = 0.0274 (132/4826). AF 95% confidence interval is 0.0236. There are 23 homozygotes in GnomAd4. There are 1066 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 2135 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.994G>A p.Ala332Thr missense_variant Exon 7 of 35 ENST00000348261.11 NP_066921.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.994G>A p.Ala332Thr missense_variant Exon 7 of 35 1 NM_021098.3 ENSP00000334198.7
CACNA1HENST00000569107.6 linkc.994G>A p.Ala332Thr missense_variant Exon 7 of 34 1 ENSP00000454990.2
CACNA1HENST00000711493.1 linkc.994G>A p.Ala332Thr missense_variant Exon 7 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.994G>A p.Ala332Thr missense_variant Exon 7 of 34 1 ENSP00000455840.1
CACNA1HENST00000711450.1 linkc.994G>A p.Ala332Thr missense_variant Exon 7 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.994G>A p.Ala332Thr missense_variant Exon 7 of 35 1 ENSP00000457555.2
CACNA1HENST00000638323.1 linkc.955G>A p.Ala319Thr missense_variant Exon 7 of 35 5 ENSP00000492267.1
CACNA1HENST00000562079.6 linkc.994G>A p.Ala332Thr missense_variant Exon 7 of 34 1 ENSP00000454581.2
CACNA1HENST00000711438.1 linkc.955G>A p.Ala319Thr missense_variant Exon 7 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.994G>A p.Ala332Thr missense_variant Exon 7 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.994G>A p.Ala332Thr missense_variant Exon 7 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.994G>A p.Ala332Thr missense_variant Exon 7 of 36 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.994G>A p.Ala332Thr missense_variant Exon 7 of 35 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.994G>A p.Ala332Thr missense_variant Exon 7 of 34 ENSP00000518769.1
CACNA1HENST00000621827.2 linkn.994G>A non_coding_transcript_exon_variant Exon 7 of 37 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.994G>A non_coding_transcript_exon_variant Exon 7 of 34 5 ENSP00000492650.2
CACNA1HENST00000639478.1 linkn.994G>A non_coding_transcript_exon_variant Exon 7 of 35 5 ENSP00000491945.1
CACNA1HENST00000640028.1 linkn.994G>A non_coding_transcript_exon_variant Exon 7 of 35 5 ENSP00000491488.1
CACNA1HENST00000711442.1 linkn.*441G>A non_coding_transcript_exon_variant Exon 6 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.994G>A non_coding_transcript_exon_variant Exon 7 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.994G>A non_coding_transcript_exon_variant Exon 7 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.994G>A non_coding_transcript_exon_variant Exon 7 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.994G>A non_coding_transcript_exon_variant Exon 7 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.994G>A non_coding_transcript_exon_variant Exon 7 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.994G>A non_coding_transcript_exon_variant Exon 7 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.994G>A non_coding_transcript_exon_variant Exon 7 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.994G>A non_coding_transcript_exon_variant Exon 7 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.994G>A non_coding_transcript_exon_variant Exon 7 of 35 ENSP00000518777.1
CACNA1HENST00000711442.1 linkn.*441G>A 3_prime_UTR_variant Exon 6 of 34 ENSP00000518758.1

Frequencies

GnomAD3 genomes
AF:
0.0140
AC:
2137
AN:
152136
Hom.:
23
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00319
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.0173
Gnomad ASJ
AF:
0.0510
Gnomad EAS
AF:
0.000775
Gnomad SAS
AF:
0.0273
Gnomad FIN
AF:
0.0158
Gnomad MID
AF:
0.0255
Gnomad NFE
AF:
0.0177
Gnomad OTH
AF:
0.0210
GnomAD2 exomes
AF:
0.0168
AC:
4110
AN:
244950
AF XY:
0.0183
show subpopulations
Gnomad AFR exome
AF:
0.00212
Gnomad AMR exome
AF:
0.0105
Gnomad ASJ exome
AF:
0.0471
Gnomad EAS exome
AF:
0.000168
Gnomad FIN exome
AF:
0.0152
Gnomad NFE exome
AF:
0.0180
Gnomad OTH exome
AF:
0.0201
GnomAD4 exome
AF:
0.0171
AC:
24877
AN:
1458852
Hom.:
282
Cov.:
35
AF XY:
0.0177
AC XY:
12862
AN XY:
725818
show subpopulations
African (AFR)
AF:
0.00275
AC:
92
AN:
33464
American (AMR)
AF:
0.0114
AC:
510
AN:
44662
Ashkenazi Jewish (ASJ)
AF:
0.0461
AC:
1204
AN:
26094
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39686
South Asian (SAS)
AF:
0.0278
AC:
2397
AN:
86228
European-Finnish (FIN)
AF:
0.0147
AC:
749
AN:
51084
Middle Eastern (MID)
AF:
0.0387
AC:
223
AN:
5768
European-Non Finnish (NFE)
AF:
0.0167
AC:
18530
AN:
1111550
Other (OTH)
AF:
0.0194
AC:
1168
AN:
60316
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
1556
3112
4668
6224
7780
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
694
1388
2082
2776
3470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0140
AC:
2135
AN:
152254
Hom.:
23
Cov.:
33
AF XY:
0.0143
AC XY:
1066
AN XY:
74440
show subpopulations
African (AFR)
AF:
0.00318
AC:
132
AN:
41558
American (AMR)
AF:
0.0173
AC:
264
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0510
AC:
177
AN:
3472
East Asian (EAS)
AF:
0.000777
AC:
4
AN:
5150
South Asian (SAS)
AF:
0.0274
AC:
132
AN:
4826
European-Finnish (FIN)
AF:
0.0158
AC:
168
AN:
10622
Middle Eastern (MID)
AF:
0.0240
AC:
7
AN:
292
European-Non Finnish (NFE)
AF:
0.0177
AC:
1206
AN:
68004
Other (OTH)
AF:
0.0203
AC:
43
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
117
234
352
469
586
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0172
Hom.:
57
Bravo
AF:
0.0133
TwinsUK
AF:
0.0143
AC:
53
ALSPAC
AF:
0.0166
AC:
64
ESP6500AA
AF:
0.00190
AC:
8
ESP6500EA
AF:
0.0173
AC:
145
ExAC
AF:
0.0166
AC:
2000
Asia WGS
AF:
0.00924
AC:
32
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 09, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Epilepsy, childhood absence, susceptibility to, 6 Other:1
-
GenomeConnect, ClinGen
Significance:not provided
Review Status:no classification provided
Collection Method:phenotyping only

Variant interpretted as Uncertain significance and reported on 09/25/2014 by GTR ID 320384. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.27
CADD
Benign
0.20
DANN
Benign
0.95
DEOGEN2
Benign
0.34
T;.;.;.
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.046
N
LIST_S2
Benign
0.75
T;T;T;.
MetaRNN
Benign
0.0031
T;T;T;T
MetaSVM
Benign
-0.34
T
MutationAssessor
Benign
-0.40
N;.;N;N
PhyloP100
-0.96
PrimateAI
Benign
0.43
T
PROVEAN
Benign
0.36
N;.;N;N
REVEL
Benign
0.21
Sift
Benign
0.44
T;.;T;T
Sift4G
Benign
0.75
T;.;T;T
Polyphen
0.0080
B;.;B;B
Vest4
0.15
ClinPred
0.00054
T
GERP RS
3.2
Varity_R
0.049
gMVP
0.75
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs59650398; hg19: chr16-1250446; COSMIC: COSV61989295; COSMIC: COSV61989295; API